BrainAurora Schedules 28 Aug 2026 Board Meeting to Approve 1H26 Interim Results

Bulletin Express
08/18

BrainAurora Medical Technology Limited has announced that its board of directors will convene on 28 August 2026 to review and approve the Group’s interim financial results for the six months ended 30 June 2026. The meeting will also address related matters and authorise the publication of the interim report.

The announcement, dated 18 August 2026, confirms the company’s current board composition: one executive director (Chairman Tan Zheng), three non-executive directors (Deng Feng, Yang Fan and Wang Jingbo) and three independent non-executive directors (Lam Yiu Por, Dr. Duan Tao and Tu Lei).

Investors will gain clarity on BrainAurora’s half-year performance following the board’s deliberations and subsequent release of the interim results.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10